Claris Ventures has held a €30m first close for its debut fund, Claris Biotech I, which is dedicated to investments in biopharmaceutical startups in pre-clinical phase.
Claris Ventures has held a €30m first close for its debut fund, Claris Biotech I, which is dedicated to investments in biopharmaceutical startups in pre-clinical phase.